Why Moderna Stock Is Crumbling
11/6 06:56
Moderna’s stock (NASDAQ: MRNA) has plummeted over 80% in the past year, largely due to challenges in its vaccine sales. Last year, the company announced lower sales projections in Europe following the European Union’s renegotiated vaccine supply contract with Pfizer a...